News | Cardiac Imaging | February 11, 2019

New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease

Guidance document from 10 societies discusses assessment of cardiac structure and function

New Appropriate Use Criteria Outlined for Multimodality Imaging of Nonvalvular Heart Disease

February 11, 2019 — The American College of Cardiology (ACC), along with nine other cardiology professional societies, recently published a new guidance document for appropriate use criteria (AUC) for multimodality imaging in the assessment of cardiac structure and function in nonvalvular heart disease. The guidance was published online Jan. 7 in the Journal of the American College of Cardiology (JACC).

This document is the second of two companion AUC documents. The first document addresses the evaluation and use of multimodality imaging in the diagnosis and management of valvular heart disease, whereas this document addresses this topic with regard to structural (nonvalvular) heart disease. While dealing with different subjects, the two documents do share a common structure and feature some clinical overlap. The goal of the companion AUC documents is to provide a comprehensive resource for multimodality imaging in the context of structural and valvular heart disease, encompassing multiple imaging modalities.

For more information: www.acc.org

Reference

1. Doherty J.U., Kort S., Mehran R., et al. ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease. Journal of the American College of Cardiology, Jan. 7, 2019. https://doi.org/10.1016/j.jacc.2018.10.038

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Effective Jan. 1, 2020, new regulations under the Centers for Medicare & Medicaid Services (CMS) Protecting Access to Medicare Act (PAMA) will require physicians to consult a CMS-approved clinical decision support mechanism before ordering advanced imaging exams for fee-for-service Medicare patients
News | Clinical Decision Support | December 26, 2019
December 26, 2019 — Effective Jan.
 CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and medical imaging companies for the first time at the Radiological Society of North America (RSNA) 2019 meeting. With technology platforms that integrate modeled human physiology into immersive, augmented reality environments, CAE Healthcare partners with vendors to deliver risk-free training solutions that meet the needs of physicians and equipment providers. #RSNA19 #RSNA2019
News | Virtual and Augmented Reality | November 27, 2019
November 27, 2019 — CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and m
EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

News | Cardiovascular Ultrasound | November 14, 2019
November 14, 2019 — Ultromics has received 510(k) clearance from the U.S.